Coalition for Epidemic Preparedness Innovations

Coalition for Epidemic Preparedness Innovations is a global partnership between public health experts, vaccine manufacturers, and funding agencies such as the Bill and Melinda Gates Foundation, Wellcome Trust, and World Economic Forum. The organization was founded in 2017 by these entities, along with the Norwegian Ministry of Foreign Affairs, to accelerate the development of vaccines against emerging infectious diseases like Ebola, SARS, and MERS. The coalition works closely with World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Institutes of Health (NIH) to identify and address potential epidemics. Key partners include Pfizer, GlaxoSmithKline, and Sanofi Pasteur, as well as academic institutions like Harvard University and University of Oxford.

● Introduction

The Coalition for Epidemic Preparedness Innovations aims to fill the gap in vaccine development for emerging diseases by providing funding and technical support to researchers and manufacturers. This effort is crucial, as outbreaks of infectious diseases like COVID-19, H1N1, and HIV/AIDS have significant impacts on global health and economies, as seen in the responses of World Bank, International Monetary Fund, and United Nations. The coalition's work is informed by the experiences of CDC, WHO, and European Centre for Disease Prevention and Control (ECDC) in responding to public health emergencies. By collaborating with industry leaders like Johnson & Johnson, Merck & Co., and AstraZeneca, the coalition can leverage expertise and resources to develop effective vaccines and diagnostics.

● History

The concept of the Coalition for Epidemic Preparedness Innovations was first discussed at the World Economic Forum in Davos in 2016, where Bill Gates and Jeremy Farrar of the Wellcome Trust emphasized the need for a coordinated global response to emerging diseases. The coalition was officially launched in 2017 at the World Economic Forum in Davos, with an initial investment of $460 million from Bill and Melinda Gates Foundation, Wellcome Trust, and the Norwegian Ministry of Foreign Affairs. Since its inception, the coalition has worked closely with global health organizations like WHO, UNICEF, and Gavi, the Vaccine Alliance to support vaccine development and distribution efforts, including those led by Pfizer, GlaxoSmithKline, and Sanofi Pasteur.

● Mission_and_Objectives

The mission of the Coalition for Epidemic Preparedness Innovations is to accelerate the development of vaccines against emerging infectious diseases and to ensure equitable access to these vaccines for people in low- and middle-income countries. The coalition's objectives include identifying and prioritizing potential epidemics, supporting research and development of vaccines and diagnostics, and facilitating collaboration among global health stakeholders, such as CDC, NIH, and European Medicines Agency. The coalition also works to strengthen health systems and build capacity for vaccine development and distribution in low-resource settings, with partners like World Bank, International Rescue Committee, and Save the Children.

● Research_and_Development

The Coalition for Epidemic Preparedness Innovations supports research and development of vaccines and diagnostics for emerging infectious diseases through funding and technical assistance. The coalition has partnered with academic institutions like University of Oxford, Harvard University, and Stanford University to support research on vaccine candidates and diagnostic tools. The coalition also collaborates with industry partners like Pfizer, GlaxoSmithKline, and Sanofi Pasteur to accelerate the development and manufacturing of vaccines and diagnostics, with support from regulatory agencies like FDA and EMA. Additionally, the coalition works with global health organizations like WHO, UNICEF, and Gavi, the Vaccine Alliance to support vaccine distribution and delivery efforts.

● Partnerships_and_Collaborations

The Coalition for Epidemic Preparedness Innovations has established partnerships with a range of global health stakeholders, including WHO, CDC, NIH, and European Centre for Disease Prevention and Control (ECDC). The coalition also collaborates with industry leaders like Johnson & Johnson, Merck & Co., and AstraZeneca to leverage expertise and resources for vaccine development and distribution. Furthermore, the coalition works with academic institutions like University of California, Berkeley and Massachusetts Institute of Technology to support research and innovation in vaccine development and diagnostics. The coalition's partnerships also include non-governmental organizations like Red Cross, Doctors Without Borders, and Save the Children, as well as government agencies like US Department of Health and Human Services and European Commission.

● Funding_and_Governance

The Coalition for Epidemic Preparedness Innovations is funded by a range of donors, including Bill and Melinda Gates Foundation, Wellcome Trust, and the Norwegian Ministry of Foreign Affairs. The coalition's governance structure includes a board of directors comprising representatives from founding partners and independent experts. The coalition is headquartered in Oslo, Norway, and is led by a chief executive officer who oversees the organization's strategy and operations. The coalition's funding model is designed to support sustainable and equitable access to vaccines and diagnostics for people in low- and middle-income countries, with support from development banks like World Bank and Asian Development Bank.

● Impact_and_Achievements

The Coalition for Epidemic Preparedness Innovations has made significant progress in supporting the development of vaccines and diagnostics for emerging infectious diseases. The coalition has funded research on vaccine candidates for Ebola, Lassa fever, and MERS, and has supported the development of diagnostic tools for COVID-19 and other emerging diseases. The coalition's efforts have also contributed to the strengthening of health systems and build capacity for vaccine development and distribution in low-resource settings. The coalition's work has been recognized by global health leaders like WHO Director-General Tedros Adhanom Ghebreyesus and Bill Gates, and has been supported by governments and philanthropic organizations around the world, including US Agency for International Development and United Kingdom Department for International Development.

Category:Global health organizations